Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 26, 2021 08:00 ET | Source: Clearmind Medicine

Clearmind Signs Development and Supply Agreement to Produce Its Drug Candidate MEAI Psychedelic Molecule With Aragen Life Sciences

TORONTO, Ontario, Oct. 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
October 14, 2021 08:00 ET | Source: Clearmind Medicine

Clearmind Medicine Appoints Distinguished Addiction Experts Professor Wim van den Brink and Professor Gabriele Fischer to Its Scientific Advisory Board

TORONTO, Ontario, Oct. 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
October 13, 2021 08:00 ET | Source: Clearmind Medicine

Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy

TORONTO, Ontario, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
October 07, 2021 08:00 ET | Source: Clearmind Medicine

Clearmind Medicine Partners With Clinipace to Commence Processes Towards FDA Approval

Toronto, Ontario, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
October 01, 2021 08:00 ET | Source: Clearmind Medicine

Clearmind Medicine to Host ‘Psychedelics for Alcoholism‘ Virtual Educational Event on October 20

TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery and...
September 21, 2021 07:00 ET | Source: Clearmind Medicine

Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug

TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery...
August 03, 2021 07:00 ET | Source: Clearmind Medicine

Mark Haden, Psychedelic Medicine Expert, Joins Clearmind Medicine’s Advisory Board

Toronto, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery and development of...
July 20, 2021 07:00 ET | Source: Clearmind Medicine

Clearmind Issues Shareholder Letter

Toronto, July 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire-- Clearmind Medicine Inc. (CSE: CMND) ("Clearmind" or the "Company"), a psychedelic medicine biotech company focused on the discovery and...